Ligand Pharmaceuticals Inc. (LGND)
NASDAQ · Manufacturing · Pharmaceutical preparations
$301.52+$2.48 (+0.83%) on the dayAs of the close; data may be delayed.
LGND price, last 12 months
Key stats
- Previous close
- $299.04
- Open
- $300.20
- Day range
- $293.90 – $305.35
- 52-week range
- $163.45 – $326.63
- Volume
- 204.4K
- Avg volume (20 days)
- 221.3K
- Market cap
- $6.0B
Performance
1W+6.4%
1M+4.8%
3M−0.7%
6M+48.0%
YTD+59.5%
1Y+78.5%
vs S&P 500, 1Y+61.7 pts
Technicals and fundamentals
About Ligand Pharmaceuticals Inc.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $6.0B